Lv1
18 积分 2024-04-22 加入
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
8个月前
已完结
Prevalence and trend of biopsy-proven IgA nephropathy in China: a systematic review
11个月前
已完结
Atrasentan in Patients with IgA Nephropathy
11个月前
已完结
Atrasentan in Patients with IgA Nephropathy
11个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
1年前
已完结
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
1年前
已完结
Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin
1年前
已关闭
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia
1年前
已完结
Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation
1年前
已关闭
Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study A Randomized Controlled Study of Benazepril and Losartan in Chronic Renal Insufficiency
1年前
已完结
皖公网安备34019202002308
